Company Filing History:
Years Active: 1990-2006
Title: Kwon H Kim: Innovator in Transnasal Anticonvulsive Compositions
Introduction
Kwon H Kim is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative methods for administering anticonvulsive agents. With a total of 4 patents to his name, his work has the potential to greatly impact the treatment of seizure disorders.
Latest Patents
Kwon H Kim's latest patents focus on transnasal anticonvulsive compositions and modulated processes. One of his notable inventions is a novel method of vehicle modulated administration of an anticonvulsive agent to the mucous membranes of humans and animals. This method utilizes an aqueous pharmaceutical carrier that includes an aliphatic alcohol (10–80%) or a glycol (10–80%), combined with a biological surfactant such as a bile salt or lecithin. The pharmaceutical composition is designed to control and enhance the rate and extent of transmucosal permeation and absorption of the medicaments through both single and multiple administrations. Notably, nasal administration of this preparation can achieve a high plasma concentration of the anticonvulsant almost as quickly as intravenous administration. This innovation is particularly beneficial for the prompt treatment of patients experiencing status epilepticus and other fever-induced seizures.
Career Highlights
Throughout his career, Kwon H Kim has worked with reputable companies in the pharmaceutical industry. He has been associated with SK Corporation and Hoechst Roussel Pharmaceuticals, where he has contributed to various projects and advancements in drug delivery systems.
Collaborations
Kwon H Kim has collaborated with several professionals in his field, including Yong Moon Choi and Lianli Li. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in pharmaceutical compositions.
Conclusion
Kwon H Kim's work in transnasal anticonvulsive compositions showcases his dedication to improving medical treatments for seizure disorders. His innovative approaches and collaborations highlight the importance of research and development in the pharmaceutical industry.